PROVIDER PROFILE · NPI 1588985923

Mark FavotM.D.

PRESCRIBING · PART D · 2024
Total Rx claims
12
Beneficiaries
—
Total drug cost
$32
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Naproxen12 claims
QUALITY · MIPS · 2024
Final MIPS score
87.3
Quality
70.9
Cost
92.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.52%
Group
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

Hospital
Hospital